[1]
Juan-Carpena, G. et al. 2025. Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital. Acta Dermato-Venereologica. 105, (Jan. 2025), adv42023. DOI:https://doi.org/10.2340/actadv.v105.42023.